Refractory status epilepticus.

Simple item page
dc.contributor.authorMurthy, J M Ken_US
dc.date.accessioned2006-12-23en_US
dc.date.accessioned2009-06-03T12:14:28Z
dc.date.available2006-12-23en_US
dc.date.available2009-06-03T12:14:28Z
dc.date.issued2006-12-23en_US
dc.description73 references.en_US
dc.description.abstractRefractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance. Early termination of convulsive SE by aggressive treatment is the best way to prevent RSE. RSE once develop, requires more aggressive treatment as it is associated with higher mortality and morbidity. To date, no randomized controlled trials have been done for RSE. The most experience exists with coma inducing agents like pentobarbital, midazolam and propofol. New evidence suggests for the possible role of newer AEDs.en_US
dc.description.affiliationDepartment of Neurology, The Institute of Neurological Sciences, CARE Hospital, Nampally, Hyderabad - 500 001, India. jmkmurthy@satyam.net.inen_US
dc.identifier.citationMurthy JM. Refractory status epilepticus. Neurology India. 2006 Dec; 54(4): 354-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/121422
dc.language.isoengen_US
dc.source.urihttps://neurologyindia.comen_US
dc.subject.meshAnticonvulsants --therapeutic useen_US
dc.subject.meshElectroencephalographyen_US
dc.subject.meshHumansen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshStatus Epilepticus --diagnosisen_US
dc.titleRefractory status epilepticus.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Neurology India